Clinical Trial Update: Lubiprostone in Patients With Multiple Sclerosis Associated Constipation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating lubiprostone for constipation in patients with multiple sclerosis has completed, with results posted in December 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Multiple Sclerosis

Drugs mentioned

• Amitiza (lubiprostone)

Snippet

Sponsor: University of Rochester | Conditions: Multiple Sclerosis, Constipation | Phase 4 | Status: COMPLETED | Results posted: 2015-12-10